ELAPRASE: Clinical Trials

3 trials of ELAPRASE, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Withdrawn 1

Follow ELAPRASE: new trials by email Literature Review of ELAPRASE trials Research Report on ELAPRASE

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)
ELAPRASE, Rituximab, Methotrexate - Mucopolysaccharidosis (MPS), Hunter Syndrome
Phase 4WithdrawnTakeda2023-02-282025-12-09
A Study of Elaprase in Children and Adults With Hunter Syndrome (Mucopolysaccharidosis II) in India
Elaprase - Hunter Syndrome
Phase 4CompletedTakeda52022-04-212025-01-23
Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy
Idursulfase - Hunter Syndrome, Mucopolysaccharidosis II
Phase 4CompletedShire282007-12-312021-06-08

Conditions studied

Mucopolysaccharidosis II (3)  ·  Lysosomal Storage Diseases (1)  ·  Mucopolysaccharidoses (1)  ·  Sudden Infant Death (1)

Sponsors

Takeda (2)  ·  Shire (1)

Countries

Brazil (1)  ·  India (1)  ·  Poland (1)  ·  Taiwan (1)  ·  United States (1)

Results publications

PMID 25902842